OTC : CTTH
$0.01 (8.2%)
18
0
-$
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-12-17 | P-Purchase | 0.055 | 2025-12-17 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | director | 2025-11-20 | P-Purchase | 0.04 | 2025-11-24 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-11-20 | P-Purchase | 0.04 | 2025-11-21 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-10-31 | P-Purchase | 0.06 | 2025-10-31 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-09-23 | P-Purchase | 0.06 | 2025-10-07 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-08-02 | P-Purchase | 0.045 | 2025-09-23 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-08-01 | A-Award | 0.04 | 2025-09-23 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-08-01 | P-Purchase | 0.035 | 2025-08-01 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-07-08 | P-Purchase | 0.03 | 2025-07-08 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-06-26 | P-Purchase | 0.025 | 2025-06-30 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-06-23 | P-Purchase | 0.025 | 2025-06-23 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2024-06-13 | P-Purchase | 0.025 | 2025-06-13 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-06-09 | P-Purchase | 0.05 | 2025-06-09 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-04-11 | A-Award | 0.06 | 2025-06-09 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-04-09 | P-Purchase | 0.065 | 2025-04-10 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-03-31 | P-Purchase | 0.05 | 2025-03-31 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-03-11 | P-Purchase | 0.06 | 2025-03-14 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-03-07 | P-Purchase | 0.09 | 2025-03-10 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2025-02-05 | P-Purchase | 0.12 | 2025-02-06 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | officer: CEO | 2024-11-25 | P-Purchase | 0.06 | 2024-11-26 |